Clinical Trial Update: A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Simmitinib to chemotherapy for advanced esophageal squamous cell carcinoma is not yet recruiting. Sponsor: Shanghai Runshi Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Simmitinib (simmitinib)

Snippet

Sponsor: Shanghai Runshi Pharmaceutical Technology Co., Ltd | Conditions: Advanced Oesophageal Squamous Cell Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING